Skip to content

Debt-to-equity at other companies

IAR
Integra LifeSciencesIART
1.9×+0.6×
MiMedx Group logo
MiMedx GroupMDXG
0.1×0.0×
Organogenesis Holdings Inc. logo
Organogenesis Holdings Inc.ORGO
0.2×0.0×
Solventum logo
SolventumSOLV
1.2×-1.3×
The Beauty Health Company logo
The Beauty Health CompanySKIN
2.3×+2.0×
ClearPoint Neuro logo
ClearPoint NeuroCLPT
3.4×+3.2×

Other financials

Income statement

See full
Revenue$9.6M+3.1%
Gross profit$7.4M+0.8%
Operating income-$1.1M-287%
Net income-$1.4M+76.5%
EPS (diluted)-$0.17+76.4%

Balance sheet

See full
Cash & equivalents$10.8M+26.8%
Total debt$21.7M+5,319%
Total equity$1.8M+109%
Total assets$37.1M+20.2%

Cash flow

See full
Operating cash flow$397.0K+126%
CapEx$23.0K-85.8%
Free cash flow$374.0K+122%

Valuation

See full
Market cap$85.99M+10.0%
Enterprise value$96.88M
P/E5.2×
P/S1.9×

Profitability

See full
Gross margin76.7%+0.1pp
Operating margin7.3%-8.6pp
Net margin37.2%+21.6pp
FCF margin9%

Returns & leverage

See full
Return on equity-173.8%
Current ratio1.3×+0.9×

Where this comes from

Calculated from SANUWAVE Health, Inc.’s reported figures.

Based on the most recent quarter.

The official record: SANUWAVE Health, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about SANUWAVE Health, Inc.'s debt-to-equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SANUWAVE Health, Inc.'s debt-to-equity?
SANUWAVE Health, Inc. (SNWV) reported debt-to-equity of 11.8× in Q1 2026.
What does debt-to-equity mean?
Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.